SCHEMBL24102707

SCHEMBL24102707

NCc1cc(Br)ccc1CO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.43
CYP2A6 P11509 1/20 0.43
CCR5 P51681 1/20 0.40
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
NPC1 O15118 3/20 0.36
SLC6A3 Q01959 1/20 0.36
CHEK1 O14757 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 1/20 0.33
GFER P55789 1/20 0.33
ALOX15 P16050 1/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30219182 1.00 PTGDR2 (0.43) PTGDR2CYP2A6CCR5SLC6A2SLC6A4
SCHEMBL19603220 0.91 PTGDR2 (0.43) PTGDR2CYP2A6CCR5SLC6A2SLC6A4
SCHEMBL29417721 0.86 PTGDR2 (0.48) PTGDR2CYP2A6SLC6A2SLC6A4NPC1
SCHEMBL3390800 0.86 CYP2A6 (0.48) PTGDR2CYP2A6CCR5ALDH1A1MAPT
SCHEMBL795719 0.86 PTGDR2 (0.48) PTGDR2CYP2A6SLC6A2SLC6A4NPC1
SCHEMBL8128901 0.80 PTGDR2 (0.44) PTGDR2SLC6A2SLC6A4NPC1SLC6A3
SCHEMBL16793967 0.79 CYP2A6 (0.41) PTGDR2CYP2A6CCR5SLC6A2SLC6A4
SCHEMBL29676561 0.79 CYP2A6 (0.41) PTGDR2CYP2A6CCR5SLC6A2SLC6A4
SCHEMBL31185057 0.78 PTGDR2 (0.43) PTGDR2SLC6A2SLC6A4NPC1SLC6A3
SCHEMBL22604398 0.78 PTGDR2 (0.43) PTGDR2SLC6A2SLC6A4NPC1SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115667269-A Pyridone-containing fused ring derivative inhibitor, and preparation method and application thereof 上海翰森生物医药科技有限公司 2023-01-31 CN disclosed
WO-2021249522-A1 PYRIDONE-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海翰森生物医药科技有限公司 2021-12-16 WO disclosed
CN-106459002-A Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases 比奥根MA公司 2017-02-22 CN disclosed
CN-104903296-A Dihydropyrazole GPR40 modulators BRISTOL MYERS SQUIBB CO 2015-09-09 CN disclosed
CN-102803238-A Oxadiazole derivatives MERCK SERONO SA 2012-11-28 CN disclosed
CN-101094827-B Benzene compound having two or more substituents DAIICHI SANKYO CO LTD 2012-06-13 CN disclosed
CN-102459206-A Oxadiazole derivatives MERCK SERONO SA 2012-05-16 CN disclosed
CN-101792436-A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1 ASTRAZENECA R & D SODERTALJE 2010-08-04 CN disclosed
CN-101522637-A Benzimidazole derivatives useful for the treatment of vanilloid receptor 1-related disorders ASTRAZENECA AB (SE) 2009-09-02 CN disclosed
CN-101203512-A Heterocyclic compounds DAIICHI SANKYO CO LTD (JP) 2008-06-18 CN disclosed
CN-101094827-A Benzene compound having two or more substituents SANKYO CO (JP) 2007-12-26 CN disclosed